Cupid Limited has informed the Exchange regarding a press release dated January 02, 2026, titled "Q3FY26 Business Updates.".
CUPID · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cupid Limited shared a Q3 FY26 business update reporting its best-performing quarter to date, backed by its highest-ever order book and strong execution across segments. Management expressed confidence of surpassing its earlier FY26 guidance of ₹335 crore in revenue and ₹100 crore in PAT. Capacity expansion at the Palava, Maharashtra facility is progressing on schedule, which will eventually add ~770 million male condoms and ~75 million female condoms per year. The company received in-principle board approval for a new FMCG manufacturing facility in Saudi Arabia, targeted for completion by March 2027, as part of its GCC expansion strategy. Recent product launches in FMCG (Petroleum Jelly, Face Wash, Talcum Powder) are gaining traction, and upcoming CE certifications for 4 IVD kits and WHO prequalification for the Malaria IVD kit and Version 3 Female Condom will support international growth.
Positive for shareholders — the company is set to beat its own FY26 targets, order visibility is at a record high, and international/regulatory milestones are opening new growth avenues. The Saudi facility adds a long-term growth lever, though execution and regulatory risks remain until 2027.